'Reverse vaccine' for Type 1 diabetes seems to pass human test

In the first trial with human subjects, it reduced the number of immune system 'killer' cells that attack crucial insulin-producing cells, study shows.A "reverse vaccine" that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said.

Read the whole article on LA Times - Health

More from LA Times - Health